Avital Shadovitz, | |
386 Route 59, Airmont, NY 10952-3428 | |
(845) 368-7927 | |
Not Available |
Full Name | Avital Shadovitz |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 386 Route 59, Airmont, New York |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003498742 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
Provider Name | Hamaspik Of Rockland County, Inc. |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1306508700 PECOS PAC ID: 7517357650 Enrollment ID: O20211206000440 |
News Archive
Clinical Genomics Pty. Ltd (Sydney, Australia) and The Garvan Institute of Medical Research (Sydney, Australia) today announced that they have entered into a license agreement in relation to novel biomarkers discovered by scientists at the Garvan Institute. Under the terms of the agreement, Clinical Genomics obtains worldwide exclusive rights to the Garvan's proprietary cancer associated methylation DNA biomarkers for the diagnosis and or treatment of colorectal cancer.
Supervised medication delivery or simplified dosing regimens may be needed to ensure that HIV-infected patients with a history of alcohol problems stick to their medication regimens, according to a new study by researchers at Boston University Medical Center.
Faces tell the stories in UC Riverside Professor Larry Rosenblum's ecological listening lab, as volunteer test subjects show that they can "read" unheard speech - not just from lips, but from the simple movements of dots placed on lips, teeth and tongue.
Warning that patients could be at risk, an interdisciplinary group of multinational investigators is calling on the U.S. Congress and federal regulators to tighten a law that permits use of brain devices to treat rare neuropsychiatric disorders without supporting clinical trials or stringent patient oversight.
Fluxion Biosciences, Inc. announced today that a lawsuit alleging patent infringement had been filed against it in the US District Court of Northern California by Cellectricon AB, its competitor in the field of automated ion channel screening systems for drug discovery. Cellectricon has asserted U.S. Patents Nos. 7,390,650, 7,470,518, and 7,563,614 in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros and licensed to Cellectricon.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Avital Shadovitz, 20 Voyager Ct, Monsey, NY 10952-1647 Ph: (323) 316-5113 | Avital Shadovitz, 386 Route 59, Airmont, NY 10952-3428 Ph: (845) 368-7927 |
News Archive
Clinical Genomics Pty. Ltd (Sydney, Australia) and The Garvan Institute of Medical Research (Sydney, Australia) today announced that they have entered into a license agreement in relation to novel biomarkers discovered by scientists at the Garvan Institute. Under the terms of the agreement, Clinical Genomics obtains worldwide exclusive rights to the Garvan's proprietary cancer associated methylation DNA biomarkers for the diagnosis and or treatment of colorectal cancer.
Supervised medication delivery or simplified dosing regimens may be needed to ensure that HIV-infected patients with a history of alcohol problems stick to their medication regimens, according to a new study by researchers at Boston University Medical Center.
Faces tell the stories in UC Riverside Professor Larry Rosenblum's ecological listening lab, as volunteer test subjects show that they can "read" unheard speech - not just from lips, but from the simple movements of dots placed on lips, teeth and tongue.
Warning that patients could be at risk, an interdisciplinary group of multinational investigators is calling on the U.S. Congress and federal regulators to tighten a law that permits use of brain devices to treat rare neuropsychiatric disorders without supporting clinical trials or stringent patient oversight.
Fluxion Biosciences, Inc. announced today that a lawsuit alleging patent infringement had been filed against it in the US District Court of Northern California by Cellectricon AB, its competitor in the field of automated ion channel screening systems for drug discovery. Cellectricon has asserted U.S. Patents Nos. 7,390,650, 7,470,518, and 7,563,614 in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros and licensed to Cellectricon.
› Verified 2 days ago
Shimon Neuman, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7 Murray Dr, Airmont, NY 10952 Phone: 845-659-8606 Fax: 845-782-5849 | |
Mrs. Pesyl Miriam Berman, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 386 Route 59, Suite 102, Airmont, NY 10952 Phone: 845-368-7927 | |
Kerri Donahue, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4 Margo Ct, Airmont, NY 10901 Phone: 845-300-7775 | |
Judi Dobner Speech Therapy Pllc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 386 Route 59 Ste 102, Airmont, NY 10952 Phone: 845-368-7927 Fax: 845-388-7929 | |
Mrs. Yisha Schwartz, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 386 Route 59, Suite 102, Airmont, NY 10952 Phone: 845-368-7927 | |
Mrs. Randy C Dorfman, M.A. CCC-SLP, BRS-FD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15 Algonquin Cir, Airmont, NY 10952 Phone: 845-426-6595 Fax: 845-578-1502 |